Pentwater Capital Management LP - Jan 8, 2025 Form SCHEDULE 13D/A Schedule Report for Poseida Therapeutics, Inc. (PSTX)

Filing Manager: Pentwater Capital Management LP
Reporting Manager: Pentwater Capital Management LP
Security: Poseida Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: PSTX
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Date filed: 1/13/2025, 04:05 PM
Date of event: Jan 8, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Pentwater Capital Management LP	0%	0	0	0	/s/ Matthew Halbower	By: Halbower Holdings, Inc., General Partner, By: Matthew Halbower, Chief Executive Officer	0001425851
Matthew Halbower	0%	0	0	0	/s/ Matthew Halbower	By: Halbower Holdings, Inc., General Partner, By: Matthew Halbower, Chief Executive Officer